Carson Wealth (CWM LLC)’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
Carson Wealth (CWM LLC)'s HQL Position: Q1 2026 in Review
Carson Wealth (CWM LLC) increased its abrdn Life Sciences Investors (HQL) stake by 4,429% in Q1 2026, buying an estimated $164K and bringing the position to 10,055 shares worth $164K. The position accounts for ﹤0.01% of the portfolio, ranked #2895.
Carson Wealth (CWM LLC) first reported a position in HQL in Q1 2019 and has held it in 28 quarters since. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- Carson Wealth (CWM LLC) held 10,055 shares of abrdn Life Sciences Investors worth $164K as of Q1 2026.
- Carson Wealth (CWM LLC) bought 9,833 abrdn Life Sciences Investors shares in Q1 2026, an estimated $164K.
- abrdn Life Sciences Investors made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2895 holding.
- Carson Wealth (CWM LLC) first reported a position in abrdn Life Sciences Investors in Q1 2019 and has held it in 28 quarters since.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.